Variant report
Variant | nsv396113 |
---|---|
Chromosome Location | chr8:50200674-50202999 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:50169460..50172760-chr8:50198302..50201832,3 | K562 | blood: | |
2 | chr8:50201423..50203830-chr8:50212097..50214084,2 | K562 | blood: | |
3 | chr8:50198141..50200837-chr8:50202344..50203937,2 | K562 | blood: | |
4 | chr8:50201423..50204477-chr8:50211622..50215340,4 | K562 | blood: | |
5 | chr8:50198141..50200837-chr8:50202344..50203937,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200329907 | chr8:50201201-50201202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183660362 | chr8:50201215-50201216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141381838 | chr8:50201241-50201242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543943353 | chr8:50201286-50201287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561927731 | chr8:50201301-50201302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188710256 | chr8:50201306-50201307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542101505 | chr8:50201319-50201320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560471816 | chr8:50201334-50201335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541891822 | chr8:50201352-50201353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150823406 | chr8:50201353-50201354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527616978 | chr8:50201354-50201355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373000810 | chr8:50201386-50201387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552062781 | chr8:50201426-50201427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192842992 | chr8:50201429-50201430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375297041 | chr8:50201439-50201440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549856733 | chr8:50201455-50201456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139462293 | chr8:50201483-50201484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79687181 | chr8:50201509-50201510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547651244 | chr8:50201515-50201516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111444004 | chr8:50201516-50201517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531037123 | chr8:50201558-50201559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17664982 | chr8:50201570-50201571 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs184988816 | chr8:50201612-50201613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17721300 | chr8:50201615-50201616 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs544817796 | chr8:50201616-50201617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186943002 | chr8:50201648-50201649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563831471 | chr8:50201665-50201666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191437970 | chr8:50201672-50201673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536956206 | chr8:50201686-50201687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114074577 | chr8:50201762-50201763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144206327 | chr8:50201771-50201772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559811565 | chr8:50201825-50201826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572365023 | chr8:50201829-50201830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146567164 | chr8:50201841-50201842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376657709 | chr8:50201879-50201880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566901000 | chr8:50201894-50201895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564084957 | chr8:50201987-50201988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542288346 | chr8:50202020-50202021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140088714 | chr8:50202024-50202025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549577866 | chr8:50202089-50202090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58786651 | chr8:50202096-50202097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs398112445 | chr8:50202097-50202098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372214881 | chr8:50202100-50202101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376721007 | chr8:50202101-50202102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149818916 | chr8:50202160-50202161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530802884 | chr8:50202177-50202178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6990367 | chr8:50202210-50202211 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs115863731 | chr8:50202217-50202218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539739719 | chr8:50202269-50202270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552053048 | chr8:50202294-50202295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50201200-50201400 | Enhancers | K562 | blood |
2 | chr8:50201400-50203600 | Weak transcription | K562 | blood |